•
SP
SPRB
Spruce Biosciences, Inc. Common Stock
yahooPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
84.47M
Volume
36.26K
52W High
$240.00
52W Low
$4.28
Open
$0.00
Prev Close
$71.46
Day Range
0.00 - 0.00
About Spruce Biosciences, Inc. Common Stock
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.
Latest News
Rare Endocrinology and Metabolic Disorders Market Analysis: Emerging Trends and Future Outlook of Hypophosphatasia, Congenital Adrenal Hyperplasia, and Severe Hypertriglyceridemia | DelveInsight
GlobeNewswire Inc.•Jan 9
Spruce Biosciences, Inc. (SPRB) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research•May 13
Pfizer (PFE) Q1 Earnings and Revenues Beat Estimates
Zacks Investment Research•May 1
Spruce Biosciences (SPRB) Upgraded to Buy: Here's What You Should Know
Zacks Investment Research•Mar 27
Spruce Biosciences (SPRB) Falls 86% in a Month: Here's Why
Zacks Investment Research•Mar 21
Spruce Biosciences' Hormone Treatment Stumbles In Trials, Prompts Stock Freefall
Benzinga•Mar 14
Dow Dips Over 100 Points; Dick's Sporting Goods Earnings Top Views
Benzinga•Mar 14
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga•Mar 14